X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (76311) 76311
Newspaper Article (820) 820
Newsletter (343) 343
Book / eBook (214) 214
Magazine Article (173) 173
Book Chapter (154) 154
Conference Proceeding (52) 52
Web Resource (45) 45
Dissertation (21) 21
Book Review (17) 17
Government Document (8) 8
Publication (7) 7
Reference (6) 6
Trade Publication Article (5) 5
Streaming Video (4) 4
Paper (2) 2
Journal / eJournal (1) 1
Transcript (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67186) 67186
female (34348) 34348
male (33749) 33749
oncology (25508) 25508
middle aged (22803) 22803
adult (22689) 22689
brain neoplasms - pathology (17320) 17320
clinical neurology (16758) 16758
aged (16544) 16544
cancer (14363) 14363
animals (14299) 14299
tumors (12730) 12730
brain neoplasms - drug therapy (12576) 12576
surgery (11429) 11429
brain neoplasms - therapy (11041) 11041
radiotherapy (10788) 10788
brain (10785) 10785
child (10756) 10756
adolescent (10355) 10355
brain neoplasms - radiotherapy (10342) 10342
magnetic resonance imaging (10268) 10268
chemotherapy (10174) 10174
brain tumors (9541) 9541
prognosis (9212) 9212
brain neoplasms - secondary (8922) 8922
brain neoplasms - surgery (8830) 8830
glioblastoma (8643) 8643
treatment outcome (8429) 8429
glioma (8090) 8090
gliomas (8030) 8030
medicine & public health (7816) 7816
brain cancer (7316) 7316
retrospective studies (7254) 7254
brain neoplasms - metabolism (6907) 6907
mice (6887) 6887
cell line, tumor (6822) 6822
brain neoplasms - diagnosis (6805) 6805
combined modality therapy (6762) 6762
child, preschool (6681) 6681
radiology, nuclear medicine & medical imaging (6667) 6667
survival (6648) 6648
care and treatment (6588) 6588
neurosciences (6436) 6436
brain neoplasms - genetics (6358) 6358
metastasis (6312) 6312
glioma - pathology (6293) 6293
brain neoplasms - mortality (6029) 6029
neurology (5794) 5794
research (5507) 5507
therapy (5256) 5256
analysis (5113) 5113
brain-tumors (5073) 5073
glioblastoma - pathology (5026) 5026
expression (4970) 4970
follow-up studies (4886) 4886
aged, 80 and over (4743) 4743
radiation-therapy (4663) 4663
pediatrics (4517) 4517
glioblastoma multiforme (4494) 4494
young adult (4467) 4467
brain neoplasms - diagnostic imaging (4434) 4434
radiation therapy (4388) 4388
patients (4380) 4380
diagnosis (4294) 4294
neurosurgery (4286) 4286
tomography, x-ray computed (4282) 4282
antineoplastic agents - therapeutic use (4260) 4260
children (4184) 4184
health aspects (4182) 4182
brain - pathology (4155) 4155
glioma - drug therapy (4121) 4121
infant (4055) 4055
survival rate (3935) 3935
apoptosis (3934) 3934
glioblastoma - drug therapy (3902) 3902
antineoplastic combined chemotherapy protocols - therapeutic use (3744) 3744
survival analysis (3742) 3742
rats (3735) 3735
radiation (3703) 3703
temozolomide (3631) 3631
medicine (3556) 3556
pathology (3519) 3519
central-nervous-system (3469) 3469
brain neoplasms - complications (3385) 3385
radiosurgery (3379) 3379
time factors (3315) 3315
radiotherapy dosage (3296) 3296
immunohistochemistry (3286) 3286
cancer therapies (3269) 3269
brain metastases (3208) 3208
risk factors (3193) 3193
glioma - therapy (3051) 3051
gene expression (3029) 3029
glioma - metabolism (2899) 2899
proteins (2877) 2877
mutation (2876) 2876
neoplasms (2873) 2873
medical prognosis (2819) 2819
malignant glioma (2818) 2818
cell biology (2777) 2777
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
Online Resources - Online (37) 37
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (15) 15
Scarborough Hospital - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Gerstein Science - Circulation Desk (2) 2
UTL at Downsview - May be requested (2) 2
University College (Laidlaw) - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Baycrest Hospital - Wellness Library (1) 1
Credit Valley Hospital - Online (1) 1
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Law (Bora Laskin) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
OISE - Theses (1) 1
Providence Healthcare - Reference (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (73905) 73905
Japanese (1849) 1849
French (1113) 1113
German (1081) 1081
Russian (483) 483
Spanish (343) 343
Chinese (322) 322
Polish (189) 189
Italian (166) 166
Portuguese (108) 108
Hungarian (62) 62
Dutch (60) 60
Czech (57) 57
Danish (45) 45
Norwegian (36) 36
Hebrew (23) 23
Swedish (21) 21
Finnish (18) 18
Serbian (18) 18
Korean (14) 14
Turkish (13) 13
Croatian (11) 11
Romanian (11) 11
Bulgarian (10) 10
Slovak (10) 10
Ukrainian (5) 5
Slovenian (4) 4
Greek (3) 3
Latvian (3) 3
Arabic (2) 2
Corsican (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 03/2013, Volume 8, Issue 3, pp. 346 - 351
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
... followed by chemoradiotherapy with intensity-modulated radiation therapy (C-IMRT) for head-and-neck cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | SYSTEM | DELINEATION | IMRT | ONCOLOGY | GUIDELINES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
2012, ISBN 9780791860038, viii, 99
Book
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | PROPHYLACTIC CRANIAL IRRADIATION | ADJUVANT CHEMOTHERAPY | DRIVING PERFORMANCE | FOLLOW-UP | CELL LUNG-CANCER | BREAST-CANCER | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | NEUROCOGNITIVE FUNCTION | LOW-GRADE GLIOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
Gut, ISSN 0017-5749, 01/2012, Volume 61, Issue 1, pp. 6 - 32
These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour... 
SOMATOSTATIN-RECEPTOR SCINTIGRAPHY | PANCREATIC ENDOCRINE TUMORS | BRAIN NATRIURETIC PEPTIDE | STREPTOZOCIN PLUS FLUOROURACIL | ENETS CONSENSUS GUIDELINES | LONG-TERM SURVIVAL | HEPATIC ARTERIAL CHEMOEMBOLIZATION | ISLET-CELL TUMORS | QUALITY-OF-LIFE | LAPAROSCOPIC RADIOFREQUENCY ABLATION | GASTROENTEROLOGY & HEPATOLOGY | Prognosis | Pancreatic Neoplasms - diagnosis | Pancreatic Neoplasms - etiology | Humans | Liver Neoplasms - therapy | Lung Neoplasms - therapy | Neuroendocrine Tumors - diagnosis | Gastrointestinal Neoplasms - diagnosis | Gastrointestinal Neoplasms - therapy | Appendiceal Neoplasms - diagnosis | Appendiceal Neoplasms - etiology | Gastrointestinal Neoplasms - etiology | Liver Neoplasms - etiology | Liver Neoplasms - diagnosis | Lung Neoplasms - etiology | Quality of Life | Neuroendocrine Tumors - therapy | Appendiceal Neoplasms - therapy | Neuroendocrine Tumors - etiology | Lung Neoplasms - diagnosis | Pancreatic Neoplasms - therapy | Medical case management | Practice guidelines (Medicine) | Methods | Pathology | Chemotherapy | Algorithms | Medical imaging | Surgery | Metastasis | Family medical history | Cancer therapies | Tumors | Cancer | intestinal obstruction | neuroendocrine cells | gallbladder cancer | pancreatic pathology | decision analysis | histopathology | infective colitis | diarrhoea | Clinical decision-making | Guidelines | peptide receptors | pancreatic cancer | bilary duct carcinoma | salmonella | endocrine tumours | neuroendocrine tumours | cancer | pancreatitis | 1506 | sepsis | pancreatic endocrine tumour | pancreatic tumours
Journal Article
The American journal of pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | INHIBITION | THERAPY | PROTEIN | HUMAN-BREAST-CANCER | PATHWAY | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Regular
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. e609 - e620
Journal Article